Immutable evidence record · ticker

ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541)

Published as observed on 15 August 2026 at 10:15 BST.

ImmuneOnco Biopharmaceuticals (Shanghai) Inc. has a not yet measurable company news read. Its latest completed weekly trend is negative.

As of
15 Aug 2026, 10:15
Scope
company and instrument
Evidence
5 items
Independent sources
0
Country
Hong Kong
Sector
Healthcare
Previous read
50.000
Change

Verification

Evidence links

This is dated market research. Coverage may be delayed, incomplete or unavailable.

Cite this record:
Sharemaestro, ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541), 2026-08-15, https://sharemaestro.com/evidence/f98ac7bb-54f9-49a8-a48e-f42639d11261/
Record checksum aed0c98ee2afc0430afe95a54354af5e25c5fe2fab8a53e1b5f3c202e6920f04

Evidence context